[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 5114 Introduced in Senate (IS)]

<DOC>






117th CONGRESS
  2d Session
                                S. 5114

  To amend the Homeland Security Act of 2002 to provide training for 
    Department of Homeland Security personnel regarding the use of 
containment devices to prevent exposure to potential synthetic opioids, 
                        and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           November 16, 2022

  Mr. Brown (for himself, Mr. Grassley, Mr. Durbin, Mr. Cassidy, Mr. 
    Padilla, Mr. Wicker, Mr. Tester, and Mr. Markey) introduced the 
 following bill; which was read twice and referred to the Committee on 
               Homeland Security and Governmental Affairs

_______________________________________________________________________

                                 A BILL


 
  To amend the Homeland Security Act of 2002 to provide training for 
    Department of Homeland Security personnel regarding the use of 
containment devices to prevent exposure to potential synthetic opioids, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLES.

    This Act may be cited as the ``Prevent Exposure to Narcotics and 
Toxins Act of 2022'' or the ``PREVENT Act of 2022''.

SEC. 2. TRAINING REGARDING THE USE OF CONTAINMENT DEVICES TO PREVENT 
              POTENTIAL SYNTHETIC OPIOID EXPOSURE.

    (a) Training.--Section 416(b)(1) of the Homeland Security Act of 
2002 (6 U.S.C. 216(b)(1)) is amended by adding at the end the 
following:
                    ``(C) How to use containment devices to prevent 
                potential synthetic opioid exposure.''.
    (b) Availability of Containment Devices.--Section 416(c) of such 
Act (6 U.S.C. 216(c)) is amended--
            (1) in the subsection heading, by inserting ``, Containment 
        Devices,'' after ``Equipment''; and
            (2) by striking ``and opioid receptor antagonists, 
        including naloxone'' and inserting ``, opioid receptor 
        antagonists, including naloxone, and containment devices''.
    (c) Applicability to Other Components.--If the Secretary of 
Homeland Secretary determines that officers, agents, other personnel, 
or canines of a component of the Department of Homeland Security other 
than U.S. Customs and Border Protection are at risk of potential 
synthetic opioid exposure in the course of their duties, the head of 
such component shall carry out the responsibilities under section 416 
of the Homeland Security Act of 2002 (6 U.S.C. 216) in the same manner 
and to the same degree as the Commissioner of U.S. Customs and Border 
Protection carries out such responsibilities.
                                 <all>